Angus Chen draws on his legal and scientific background to strategically navigate the dynamic area at the intersection of law and science. Dr. Chen’s practice benefits from his prior experience as in-house Patent Counsel for a specialty pharmaceutical company, which has provided him with the ability to effectively integrate clients’ interests and a business perspective into his practice. Dr. Chen’s work at Haug Partners focuses on intellectual property litigation, counseling, opinion and agreement work. He specializes in the pharmaceutical patent and regulatory laws under the Hatch-Waxman Amendments to the Federal Food, Drug & Cosmetic Act. Dr. Chen has extensive experience working with pharmaceutical and biotechnology companies, including with respect to patent and regulatory strategies, lifecycle management, and settlement agreements.
